Hello CRISPR Medicine News Readers

Safer genome editing through benchmarking of Cas nucleases

Different kinds of natural and engineered Cas nucleases differ in their binding and cleavage specificities. These differences are essential to consider when deciding which nuclease to use for a given purpose. A new platform for massive parallel kinetic profiling, NucleaSeq, reveals standardised benchmarks of Cas nucleases. This can help scientists when designing experiments and might lead to more efficient and safer gene editing therapies.

CRISPR Medicine Jobs is Coming Soon!

Did you see that we will launch the first targeted recruitment platform for CRISPR-related jobs later this month? Soon, prospective employers and job seekers from all over the world will be able to use this unique platform to find highly skilled scientists and exciting jobs within the CRISPR Medicine field!

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com.

We love hearing from readers!

Happy Reading!

Gorm

P.S. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you could sign up for our newsletter yourself here.